Chronic Kidney Disease as a Coronary Artery Disease Risk Equivalent

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Current Cardiology Reports

• Publication date

  2013-01-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11886-012-0340-4PMID 23338722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study.

  2012cited by this paper
• Lipid disorders in uremia and dialysis.

  2012cited by this paper
• Chronic kidney disease: a coronary heart disease equivalent?

  2012cited by this paper
• Biomarkers determining cardiovascular risk in patients with kidney disease.

  2012cited by this paper
• Management of hyperglycemia, dyslipidemia, and albuminuria in patients with diabetes and CKD: a systematic review for a KDOQI clinical practice guideline.

  2012cited by this paper
• Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

  2012cited by this paper
• Pros and cons of aggressive blood pressure lowering in patients with type 2 diabetes.

  2012cited by this paper
• Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.

  2012cited by this paper
• Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis.

  2012cited by this paper
• Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.

  2011cited by this paper
• Estimated Glomerular Filtration Rate and Albuminuria as Predictors of Outcomes in Patients With High Cardiovascular Risk

  2011cited by this paper
• Inflammation as a risk factor and target for therapy in chronic kidney disease

  2011cited by this paper
• Role of calcium-phosphate deposition in vascular smooth muscle cell calcification.

  2011cited by this paper
• The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

  2011cited by this paper
• Using Proteinuria and Estimated Glomerular Filtration Rate to Classify Risk in Patients With Chronic Kidney Disease

  2011cited by this paper
• Serum creatinine vs. albuminuria as biomarkers for the estimation of cardiovascular risk.

  2010cited by this paper
• Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

  2010cited by this paper
• Increased Plasma and Endothelial Cell Expression of Chemokines and Adhesion Molecules in Chronic Kidney Disease

  2009cited by this paper
• Renal Dysfunction Potentiates Foam Cell Formation by Repressing ABCA1

  2009cited by this paper
• Effect of particle size on hydroxyapatite crystal-induced tumor necrosis factor alpha secretion by macrophages.

  2008cited by this paper
• Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.

  2008cited by this paper
• Sequential Activation of Matrix Metalloproteinase 9 and Transforming Growth Factor &bgr; in Arterial Elastocalcinosis

  2008cited by this paper
• Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

  2008cited by this paper
• Calcium Phosphate Crystals Induce Cell Death in Human Vascular Smooth Muscle Cells: A Potential Mechanism in Atherosclerotic Plaque Destabilization

  2008cited by this paper
• Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP).

  2007cited by this paper
• The Framingham predictive instrument in chronic kidney disease.

  2007cited by this paper
• Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice.

  2006cited by this paper
• Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction.

  2006cited by this paper
• Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease.

  2005cited by this paper
• Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study.

  2005cited by this paper
• Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

  2004cited by this paper
• Spotty Calcification Typifies the Culprit Plaque in Patients With Acute Myocardial Infarction: An Intravascular Ultrasound Study

  2004cited by this paper
• National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification

  2003cited by this paper
• The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia.

  2003cited by this paper
• Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

  2003cited by this paper
• Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

  2003cited by this paper
• Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study.

  2003cited by this paper
• Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus.

  2001cited by this paper
• Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease

  2001cited by this paper
• Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure.

  2000cited by this paper
• Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study.

  1998cited by this paper
• Accelerated atherosclerosis in prolonged maintenance hemodialysis.

  1974cited by this paper

• Ten-Year Clinical Outcomes and Cause of Death in Patients on Dialysis Undergoing Percutaneous Coronary Intervention: A Retrospective Mayo Clinic PCI Registry Analysis.

  2026cites this paper
• Prognostic Value of Estimated Glomerular Filtration Rate in Older Patients With Acute Coronary Syndrome.

  2026cites this paper
• Lipid and immunophenotypic profiles in hemodialysis patients with citrate vs. acetate dialysates

  2025cites this paper
• Chronic kidney disease in the primary care setting: A narrative review

  2025cites this paper
• Novel approaches and applications in identifying DNA methylation markers of cardio-kidney-metabolic disease

  2025cites this paper
• Correlation between B-type Natriuretic Peptide and Syntax Score in Patients of Multivessel Coronary Artery Disease Presented with Acute Coronary Syndrome

  2025cites this paper
• Identification and validation of inflammatory response genes linking chronic kidney disease with coronary artery disease based on bioinformatics and machine learning

  2025cites this paper
• Clinical epidemiology of cardiovascular disease in advanced chronic kidney disease prior to dialysis to a tertiary care centre in Bangladesh

  2024cites this paper
• Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction

  2024cites this paper
• Management of Hyperkalemia in Renin-Angiotensin-Aldosterone System Inhibitor: Strategies to Maintain Chronic Kidney Disease Patients with Type II Diabetes on Therapy

  2024cites this paper
• Non-steroidal mineralocorticoid antagonists and hyperkalemia monitoring in chronic kidney disease patients associated with type II diabetes: a narrative review

  2024cites this paper
• Risk factors and their association with mortality in patients undergoing long-term hemodialysis or/and kidney transplant patients or late-stage chronic kidney disease: A single center, prospective observational study

  2024cites this paper
• Optimal Medical Therapy for Chronic Coronary Disease in 2024: Focus on Antithrombotic Therapy.

  2024cites this paper
• Does Chronic Kidney Disease Influence Revascularization Strategy After Acute Coronary Syndrome? A Systematic Review and Meta-Analysis

  2024cites this paper
• Protective Effects of the Food Supplement Flexovital in a Model of Cardiovascular-Kidney-Metabolic Syndrome in Mice

  2024cites this paper
• The Fibrosis-4 index predicts all-cause mortality in a cohort of patients at high cardiovascular risk partly through glomerular filtration rate reduction.

  2024cites this paper
• Agile 3+ and Agile 4 scores predict chronic kidney disease development in metabolic dysfunction‐associated steatotic liver disease

  2024cites this paper
• Association between R2CHA2DS2-VASc score and three-vessel coronary artery disease in a large population at high cardiovascular risk

  2024cites this paper
• Age-related white matter change disease predicts long-term cerebrovascular morbidity following carotid endarterectomy.

  2024cites this paper
• Age and sex differences in the risk of cardiovascular diseases by chronic kidney disease in a general Japanese population

  2023cites this paper
• Navigating the Crossroads: Understanding the Link Between Chronic Kidney Disease and Cardiovascular Health

  2023cites this paper
• Association of abnormalities in electrocardiography and ultrasonic echocardiography with the occurrence of cardiovascular disease in patients with advanced chronic kidney disease

  2023cites this paper
• Deep learning-based fundus image analysis for cardiovascular disease: a review

  2023cites this paper
• CHA2DS2-VASc score as a predictor of clinical outcomes in hospitalized patients with and without chronic kidney disease

  2023cites this paper
• Postoperative outcomes, predictors and trends of mortality and morbidity in patients undergoing hip fracture surgery with underlying aortic stenosis: a nationwide inpatient sample analysis

  2023cites this paper
• The management of non‐culprit vessel(s) in patients with unstable angina/non‐ST elevation myocardial infarction and chronic kidney dysfunction

  2023cites this paper
• Nocturnal systolic blood pressure dipping and progression of chronic kidney disease

  2023cites this paper
• One-Year Mortality after Hemodialysis Initiation: The Prognostic Role of the CHA2DS2-VASc Score

  2023cites this paper
• A Reproducible Mouse Model of Moderate CKD With Early Manifestations of Osteoblastic Transition of Cardiovascular System

  2022influential citation
• Quantitative Data-Independent Acquisition Mass Spectrometry Proteomics and Weighted Correlation Network Analysis of Plasma Samples for the Discovery of Chronic Kidney Disease-Specific Atherosclerosis Risk Factors

  2022cites this paper
• Age-Related Association between Multimorbidity and Mortality in US Veterans with Incident Chronic Kidney Disease

  2022cites this paper
• Biomarkers In Hypertension And Hypertension-Related Disorders.

  2022cites this paper
• Non-High-Density Lipoprotein Cholesterol and Cardiovascular Outcomes in Chronic Kidney Disease: Results from KNOW-CKD Study

  2022cites this paper
• Coronary artery calcium and risk of chronic kidney disease in young and middle-aged adults.

  2022cites this paper
• Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease

  2022cites this paper
• MALDI mass spectrometric imaging methods for localization and identification of pathophysiological relevant regulators in tissue samples

  2022influential citation
• Impact of impaired renal function on outcomes of chronic total occlusion undergoing revascularization: a systemic review and meta-analysis

  2022cites this paper
• B lymphocytes subpopulations are associated with cardiac remodeling in elderly patients with advanced chronic kidney disease.

  2022cites this paper
• Patient-Reported Symptoms and Subsequent Risk of Myocardial Infarction in Chronic Kidney Disease

  2022influential citation
• Cause of postoperative mortality in patients with end-stage renal disease

  2022cites this paper
• Revascularization vs. Conservative Medical Treatment in Patients With Chronic Kidney Disease and Coronary Artery Disease: A Meta-Analysis

  2022influential citation
• A Systematic Review on the Correlations between Left Atrial Strain and Cardiovascular Outcomes in Chronic Kidney Disease Patients

  2021cites this paper
• Assessing the Validity of the Criteria for the Extreme Risk Category of Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based Study

  2021cites this paper
• Kidney function assessment and endpoint ascertainment in clinical trials.

  2021cites this paper
• Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease

  2021cites this paper
• Retinal microvascular function predicts chronic kidney disease in patients with cardiovascular risk factors.

  2021cites this paper
• Chronic kidney disease as a risk factor for poor outcomes after endovascular stroke intervention.

  2021cites this paper
• The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease.

  2021cites this paper
• [Vasoprotective effects hypotensive therapy in patients with coronary heart disease combined with chronic kidney disease stage 2-3 after coronary stenting].

  2021cites this paper
• Association of Blood Pressure with Cardiovascular Outcome and Mortality: Results from the KNOW-CKD Study.

  2021cites this paper
• Age, Serum Creatinine, and Left Ventricular Ejection Fraction Improved the Performance of the CatLet Angiographic Scoring System in Terms of Outcome Predictions for Patients with Acute Myocardial Infarction: A Median 4.3-Year Follow-Up Study

  2021cites this paper
• Rice Endosperm Protein Improves the Anti-Inflammatory Effects of High-Density Lipoprotein and Produces Lower Atherosclerotic Lesion Accelerated by the Renal Mass Reduction than Casein in a Mouse Model.

  2021cites this paper
• Perirenal Adipose Tissue Inflammation: Novel Insights Linking Metabolic Dysfunction to Renal Diseases

  2021cites this paper
• Intersection Between Chronic Kidney Disease and Cardiovascular Disease

  2021cites this paper
• Role of Pocket Ultrasound in Assessing Intravascular Volume to Guide Management in Heart Failure Patients with Renal Impairment

  2021cites this paper
• Safety and effectiveness of percutaneous coronary intervention using rotational atherectomy and new-generation drug-eluting stents for calcified coronary artery lesions in patients with chronic kidney disease

  2021cites this paper
• Clinical Approach to Vascular Calcification in Patients With Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects

  2021cites this paper
• Prevalence, risk factors and predicted risk of cardiac events in chronic kidney disease of uncertain aetiology in Sri Lanka: A tubular interstitial nephropathy

  2021cites this paper
• Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease

  2021cites this paper
• Mass Spectrometry-Based Lipidomics Reveals Differential Changes in the Accumulated Lipid Classes in Chronic Kidney Disease

  2021cites this paper
• A Personalized Approach to Chronic Kidney Disease and Cardiovascular Disease: JACC Review Topic of the Week.

  2021cites this paper
• Roles and mechanisms of renalase in cardiovascular disease: A promising therapeutic target.

  2020cites this paper
• Preparing for Hemodialysis

  2020cites this paper
• DEMOGRAPHIC AND CLINICAL PROFILE OF CHRONIC KIDNEY DISEASE IN TERTIARY CARE

  2020cites this paper
• Targeting Vascular Calcification in Chronic Kidney Disease

  2020cites this paper
• Implications of Kidney Disease in the Cardiac Patient.

  2020cites this paper
• Bypass Grafting vs Endovascular Therapy in Patients With Non-Dialysis-Dependent Chronic Kidney Disease and Chronic Limb-Threatening Ischemia (CRITISCH Registry)

  2020influential citation
• Impact of selected comorbidities on the presentation and management of aortic stenosis

  2020cites this paper
• Oxidative stress and inflammation in the development of cardiovascular disease and contrast induced nephropathy

  2020influential citation
• IVUS guided rota assisted left main zero-contrast PCI in a patient with CKD

  2020cites this paper
• Using CHADS2 and CHA2DS2-VASc scores for mortality prediction in patients with chronic kidney disease

  2020cites this paper
• The Burden of Coronary Artery Disease in Chronic Kidney Disease

  2020cites this paper
• Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis

  2020cites this paper
• Cardiac Consultative Approach to Hemodialysis Patients and Cardiovascular Evaluation and Management of Potential Kidney Transplant Recipients

  2020cites this paper
• Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus

  2020cites this paper
• Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease

  2020cites this paper
• Kidney disease

  2019cites this paper
• Non-Invasive Imaging for Evaluating Cardiovascular Involvement in Patients with Primary and Lupus Nephritis

  2019cites this paper
• Chapter 4: Cardiovascular Disease in Patients with CKD

  2019cites this paper
• Dual inhibition of endothelial miR-92a-3p and miR-489-3p reduces renal injury-associated atherosclerosis.

  2019cites this paper
• The link between anemia and adverse outcomes in patients with acute coronary syndrome

  2019cites this paper
• Accelerated Atherosclerosis in the Setting of Chronic Kidney Disease

  2019cites this paper
• Prevalence and Significance of Renal Dysfunction Among Emergency Department Observation Patients With Chest Pain.

  2019cites this paper
• Lipid-lowering agents for the treatment of hyperlipidemia in patients with chronic kidney disease and end-stage renal disease on dialysis: a review

  2019cites this paper
• Impact of baseline estimated glomerular filtration rate on inhospital outcomes of patients with ST‐elevation myocardial infarction undergoing primary percutaneous coronary intervention: A China acute myocardial infarction registry study

  2019cites this paper
• Chronic Kidney Disease And Associated Risk Factors Among Cardiovascular Patients

  2019influential citation
• The myth of ‘stable’ coronary artery disease

  2019cites this paper
• Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition

  2019cites this paper
• Prevention and treatment of stroke in patients with chronic kidney disease: an overview of evidence and current guidelines.

  2019cites this paper
• Clinical and Echocardiographic Profile of Renal Transplant Recipients

  2019cites this paper
• Lipid-lowering agents for the treatment of hyperlipidemia in patients with chronic kidney disease and end-stage renal disease on dialysis: a review

  2019cites this paper
• Renal function and non-coronary atherosclerosis progression in patients with coronary artery disease one year after coronary artery bypass

  2019cites this paper
• Clinical outcomes in patients with biopsy-proved diabetic nephropathy compared to isolated lupus or crescentic glomerulonephritis.

  2019cites this paper
• Lipoprotein Modulation of Proteinuric Renal Injury

  2019cites this paper
• End-stage renal failure is associated with impaired coronary microvascular function.

  2019cites this paper
• Exploring the Benefit of 2-Methylbutyric Acid in Patients Undergoing Hemodialysis Using a Cardiovascular Proteomics Approach

  2019cites this paper
• Cardiovascular Outcomes with the Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes and Chronic Kidney Disease: An Updated Meta-Analysis of Randomized Controlled Trials.

  2019cites this paper
• Correlation analysis between hyperphosphatemia and atherosclerosis risk in chronic kidney disease population of Southwest China

  2018cites this paper
• Lipid Management in Chronic Kidney Disease: Systematic Review of PCSK9 Targeting

  2018cites this paper
• Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism

  2018cites this paper